Treatment with tirzepatide demonstrated a 38% decrease in the risk of heart failure outcomes (composite endpoint) compared with placebo. Detailed results were announced from the phase 3 SUMMIT trial ...

HeartFlow’s AI-enabled plaque quantification technology has been upgraded to a new I CPT category code by the American Medical Association.

Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women.

Statistics from 2023 on U.S. obesity rates reveal that in every U.S. state, one in every five people now has obesity.

Tryvio (aprocitentan) is now available for difficult-to-control hypertension in combination with other antihypertensive drugs.

People with a late chronotype have an increased risk for T2D and have higher body mass index (BMI) and larger waist circumference.

There is a reciprocal relationship between asthma and type 2 diabetes (T2D), according to a study presented at the annual meeting of the European Association fo ...